Art

J-GLOBAL ID：202102222908791780   Reference number：21A0426238

The pain-relieving effects of lactoferrin on oxaliplatin-induced neuropathic pain

オキサリプラチン誘発神経障害性疼痛に対するラクトフェリンの疼痛緩和効果

Author (6)： FUJIMURA Takeshi (Department of Veterinary Medicine, Faculty of Agriculture, Tottori University, 4-101 Koyama-Minami, Tottori 680-8553, Japan) ,  IGUCHI Aiko (Department of Veterinary Medicine, Faculty of Agriculture, Tottori University, 4-101 Koyama-Minami, Tottori 680-8553, Japan) ,  SATO Atsushi (School of Bioscience and Biotechnology, Tokyo University of Technology, 1404-1 Katakura, Hachioji, Tokyo 192-0982, Japan) ,  KAGAYA Shinji (NRL Pharma, Inc., #203 KSP East, 3-2-1 Sakato, Takatsu-ku, Kawasaki, Kanagawa, 213-0012, Japan) ,  HOSHINO Tatsuo (NRL Pharma, Inc., #203 KSP East, 3-2-1 Sakato, Takatsu-ku, Kawasaki, Kanagawa, 213-0012, Japan) ,  TAKEUCHI Takashi (Department of Veterinary Medicine, Faculty of Agriculture, Tottori University, 4-101 Koyama-Minami, Tottori 680-8553, Japan)
Material： Journal of Veterinary Medical Science (Web)
Volume： 82  Issue： 11  Page： 1648-1654(J-STAGE)  Publication year： 2020 
JST Material Number： U1094A  ISSN： 1347-7439  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *mouse(animal) ,...
Semi thesaurus term： oxaliplatin ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0426238&from=J-GLOBAL&jstjournalNo=U1094A") }}

Author keywords (5)： gait dysfunction ,  lactoferrin ,  neuropathic pain ,  oxaliplatin ,  side effects

JST classification (2)： Basic neurology  (GN01020W) ,  Therapeutics in general  (GC03011J)

Reference (27)：

• 1. Candelario-Jalil, E., Mhadu, N. H., Al-Dalain, S. M., Martínez, G. and León, O. S. 2001. Time course of oxidative damage in different brain regions following transient cerebral ischemia in gerbils. Neurosci. Res. 41: 233-241.
• 2. de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., Papamichael, D., Le Bail, N., Louvet, C., Hendler, D., de Braud, F., Wilson, C., Morvan, F. and Bonetti, A. 2000. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J. Clin. Oncol. 18: 2938-2947.
• 3. Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., Portenoy, R. K., Rice, A. S., Stacey, B. R., Treede, R. D., Turk, D. C. and Wallace, M. S. 2007. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132: 237-251.
• 4. Hayashida, K., Takeuchi, T., Shimizu, H., Ando, K. and Harada, E. 2003. Lactoferrin enhances opioid-mediated analgesia via nitric oxide in the rat spinal cord. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285: R306-R312.
• 5. Hu, K., Shi, Y., Jiang, W., Han, J., Huang, S. and Jiang, X. 2011. Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson’s disease. Int. J. Pharm. 415: 273-283.

Terms in the title (6)： オキサリプラチン ,  誘発 ,  神経障害性疼痛 ,  ラクトフェリン ,  疼痛 ,  緩和効果